# Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients

Study · id `cardio:ct-nct03651557` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03651557](<https://clinicaltrials.gov/study/NCT03651557>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03651557

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT03651557. Randomized; triple masking; primary purpose treatment. Start 2018-11-29 (actual); primary completion 2021-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT03651557, source copy `cardio:ctgov-nct03651557-2019-03-06`, retrieved 2026-10-26)
- Started: 2018-11-29 (actual) (ClinicalTrials.gov record NCT03651557, source copy `cardio:ctgov-nct03651557-2019-03-06`, retrieved 2026-10-26)
- Primary completion: 2021-05 (anticipated) (ClinicalTrials.gov record NCT03651557, source copy `cardio:ctgov-nct03651557-2019-03-06`, retrieved 2026-10-26)
- Completion: 2021-05 (anticipated) (ClinicalTrials.gov record NCT03651557, source copy `cardio:ctgov-nct03651557-2019-03-06`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT03651557, source copy `cardio:ctgov-nct03651557-2019-03-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03651557-2019-03-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients
- Acronym: AWAKE
- Condition: Cardiac Arrest
- Intervention (Drug): Neu2000KWL High-dose group
- Intervention (Drug): Neu2000KWL Low-dose group
- Intervention (Drug): Placebo
- Lead sponsor: GNT Pharma
- Lead sponsor class: INDUSTRY
- Collaborator: Samsung Medical Center
- Collaborator class: OTHER
- Collaborator: Chonnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Gangnam Severance Hospital
- Collaborator class: OTHER
- Collaborator: Kyungpook National University Hospital
- Collaborator class: OTHER
- Collaborator: Pusan National University Hospital
- Collaborator class: OTHER
- Collaborator: Soonchunhyang University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: GNT Pharma (`cardio:org-gnt-pharma`)
- Registry lists this organization as a collaborator: Samsung Medical Center (`cardio:org-samsung-medical-center`)
- Registry lists this organization as a collaborator: Chonnam National University Hospital (`cardio:org-chonnam-national-university-hospital`)
- Registry lists this organization as a collaborator: Gangnam Severance Hospital (`cardio:org-gangnam-severance-hospital`)
- Registry lists this organization as a collaborator: Kyungpook National University Hospital (`cardio:org-kyungpook-national-university-hospital`)
- Registry lists this organization as a collaborator: Pusan National University Hospital (`cardio:org-pusan-national-university-hospital`)
- Registry lists this organization as a collaborator: Soonchunhyang University Hospital (`cardio:org-soonchunhyang-university-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Nelonemdaz Treatment for Patients With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial (`cardio:pubmed-39899673`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0011a7c6467a69a0cb99bfd968dba8fd9aa57324432ca6226724105a77dd7885
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
